Under the agreement Clarity’s PET based companion diagnostics and radio-immunotherapeutics development program will receive cGMP chemistry manufacturing,scale up and aseptic fill/finish services and analytical support from Dalton Pharma.
The Company has completed testing and released the final drug product of sparvax for further clinical evaluation. PharmAthene’s rPA technology platform uses E.Coli, a technology which increases manufacturing
Amcor MediCan with aluminum container technology provides a high degree of protection to healthcare products and extends their shelf life. The packaging solution is suitable for inhalers and
The First Affiliated Hospital of Dermatology of FMMU has developed the drug, which will be used to treat skin diseases, such as bacterial and fungal infections, dermatitis and
The TCN-202 is an antibody in development for the treatment of human cytomegalovirus (CMV) infection. Theraclone Sciences CEO Clifford Stocks said TCN-202 was discovered using Theraclone’s I-STAR platform,
The study enrolled 29 patients, suffered from a variety of solid tumors, including cervical, gastric, melanoma, non-small cell lung (NSCLD), ovarian, pancreatic, prostate, thyroid, urachal and uterine cancers.
The Phase III trial evaluated the efficacy, safety and tolerability of 40mg/1ml GA administered subcutaneously three times a week compared to placebo in relapsing-remitting multiple sclerosis (RRMS) patients.
The collaboration is expected to exhance the GastroPlus simulation model for drug dosing in the oral cavity, such as sublingual, lingual and bucca dosing through a variety of
Innovimmune research team of autoimmune and immunoinflammation diseases has discovered oral small molecule cytokine inhibitors that exhibit a novel mode of binding to MIF. Innovimmune President and CEO
The (Oroeze) Benzydamine 0.15% w/v Oromucosal spray is available in the Teva 360 livery. The new product is a version of Difflam (Benzydamine) from Meda Pharmaceuticals. Teva commercial
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.